Log In
Print
BCIQ
Print
Print this Print this
 

NeoFuse

  Manage Alerts
Collapse Summary General Information
Company Mesoblast Ltd.
DescriptionAllogeneic cell therapy of mesenchymal precursor cells (MPCs) derived from adult bone marrow cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard IndicationBone repair
Indication DetailsPromote posterior lumbar and cervical interbody spinal fusion
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today